SEVREDOL

This brand name is authorized in Australia, Croatia, Cyprus, Estonia, France, Ireland, New Zealand, Poland, Romania, Spain, UK.

Active ingredients

The drug SEVREDOL contains one active pharmaceutical ingredient (API):

1	Morphine UNII 76I7G6D29C - MORPHINE
	Morphine is a narcotic analgesic obtained from opium. Morphine acts as an agonist at opiate receptors in the CNS particularly Mu and to a lesser extent Kappa receptors. Mu receptors are thought to mediate supraspinal analgesia, respiratory depression and euphoria, and Kappa receptors, spinal analgesia, miosis and sedation.
	Read more about Morphine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SEVREDOL Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02AA01	Morphine	N Nervous system → N02 Analgesics → N02A Opioids → N02AA Natural opium alkaloids
Discover more medicines within N02AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	5393W, 5394X, 8669G, 8670H
EE	Ravimiamet	1042805, 1042816, 1080470, 1080492, 1382273, 1382284, 1382295, 1382307
ES	Centro de información online de medicamentos de la AEMPS	59655, 59656
FR	Base de données publique des médicaments	60907447, 67233047
GB	Medicines & Healthcare Products Regulatory Agency	28987, 30782, 30795
HR	Agencija za lijekove i medicinske proizvode	HR-H-915182609, HR-H-932315368
IE	Health Products Regulatory Authority	45683, 45748, 68549
NZ	Medicines and Medical Devices Safety Authority	4147, 4148
PL	Rejestru Produktów Leczniczych	100102513
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W59251001, W59251002, W59251003, W59252001, W59252002, W59252003